Mastelli

Osteoarthritis (OA) is a chronic joint disease characterised by the degeneration of articular cartilage, alterations in the physicochemical properties of the synovial fluid, and macroscopic modifications of the joint. With a rich history and established leadership in the sector since 1952, Mastelli has mastered polynucleotides and Polydesoxyribonucleotides (PDRN). Offering safe and innovative solutions tailored to patients' lifestyles and needs, Mastelli stands at the forefront of regenerative medicine. They boast a comprehensive product line that adopts an all-around conservative approach to OA treatment.

Bluemotion Medical's communication strategy involves a scientifically accurate anatomical representation of the various stages of disease progression and degeneration. This visual narrative highlights the associated pain, stiffness, and loss of range of motion. Simultaneously, it depicts the precise moment of medical solution application via intra-articular infiltration, visually illustrating the fluid's distribution within the joint. Finally, the use of real patient footage effectively represents diverse patient profiles, placing the patient's life at the heart of the storytelling, perfectly aligned with current patient-centricity strategies.